New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids

Biochimica et Biophysica Acta - Biomembranes

Volumn 1828, Issue 5, 2013, Pages 1365-1373

  Arukuusk, Piret ^a   Pärnaste, Ly ^a   Oskolkov, Nikita ^a   Copolovici, Dana Maria ^a   Margus, Helerin ^a   Padari, Kärt ^a   Möll, Kaidi ^b   Maslovskaja, Julia ^b   Tegova, Radi ^b   Kivi, Gaily ^b   Tover, Andres ^b   Pooga, Margus ^a   Ustav, Mart ^b   Langel, Ülo ^a,c  

^a UNIVERSITY OF TARTU   (Estonia)

^b Icosagen Cell Factory OÜ ^*  (Estonia)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Cell penetrating peptide; Gene silencing; Plasmid transfection; Protein production; QMCF technology; Splice correction

Indexed keywords

DRUG VEHICLE; LIPOFECTAMINE; NICKFECT51; NICKFECT53; NICKFECT61; NUCLEIC ACID; OLIGONUCLEOTIDE; PLASMID DNA; RECOMBINANT ANTIBODY; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA TRANSFECTION; EMBRYO; ENDOSOME; FEMALE; GENE SILENCING; GENE VECTOR; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MOUSE; NANOPHARMACEUTICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE CHARGE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; CELL-PENETRATING PEPTIDES; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEK293 CELLS; HELA CELLS; HUMANS; JURKAT CELLS; LUCIFERASES; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NUCLEIC ACIDS; OLIGONUCLEOTIDES; PLASMIDS; RNA, SMALL INTERFERING; STEARIC ACIDS; TRANSFECTION;

EID: 84875168575     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2013.01.011     Document Type: Article

References (36)

1. A. Orlacchio, G. Bernardi, A. Orlacchio, and S. Martino RNA interference as a tool for Alzheimer's disease therapy Mini-Rev. Med. Chem. 7 11 2007 1166 1176
2. T.C. Pappas, A.G. Bader, B.F. Andruss, D. Brown, and L.P. Ford Applying small RNA molecules to the directed treatment of human diseases: realizing the potential Expert Opin. Ther. Targets 12 1 2008 115 127
3. M. Lopez-Fraga, N. Wright, and A. Jimenez RNA interference-based therapeutics: new strategies to fight infectious disease Infect. Disord. Drug Targets 8 4 2008 262 273
4. D.M. Dykxhoorn RNA interference as an anticancer therapy: a patent perspective Expert Opin. Ther. Pat. 19 4 2009 475 491
5. B.C. Ponnappa siRNA for inflammatory diseases Curr. Opin. Investig. Drugs 10 5 2009 418 424
6. J. Bauman, N. Jearawiriyapaisarn, and R. Kole Therapeutic potential of splice-switching oligonucleotides Oligonucleotides 19 1 2009 1 13
7. J.B. Opalinska, and A.M. Gewirtz Nucleic-acid therapeutics: basic principles and recent applications Nat. Rev. Drug Discov. 1 7 2002 503 514
8. H.J. Kong, and D.J. Mooney Microenvironmental regulation of biomacromolecular therapies Nat. Rev. Drug Discov. 6 6 2007 455 463
9. K.A. Whitehead, R. Langer, and D.G. Anderson Knocking down barriers: advances in siRNA delivery Nat. Rev. Drug Discov. 8 2 2009 129 138
10. A. Astriab-Fisher, D. Sergueev, M. Fisher, B.R. Shaw, and R.L. Juliano Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions Pharm. Res. 19 6 2002 744 754
11. Y. Wolf, S. Pritz, S. Abes, M. Bienert, B. Lebleu, and J. Oehlke Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides Biochemistry 45 50 2006 14944 14954
12. M. Mäe, S. El Andaloussi, P. Lundin, N. Oskolkov, H.J. Johansson, P. Guterstam, and Ü. Langel A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy J. Control. Release 134 3 2009 221 227
13. N. Oskolkov, P. Arukuusk, D.M. Copolovici, S. Lindberg, H. Margus, K. Padari, M. Pooga, and Ü. Langel NickFects, phosphorylated derivatives of Transportan 10 for cellular delivery of oligonucleotides Int. J. Pept. Res. Ther. 17 2 2011 147 157
14. A. Eguchi, B.R. Meade, Y.C. Chang, C.T. Fredrickson, K. Willert, N. Puri, and S.F. Dowdy Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein Nat. Biotechnol. 27 6 2009 567 571
15. M. Kouadir, L. Yang, R. Tan, F. Shi, Y. Lu, S. Zhang, X. Yin, X. Zhou, and D. Zhao CD36 participates in PrP (106-126)-induced activation of microglia PLoS One 7 2012 e30756
16. S. El Andaloussi, T. Lehto, I. Mager, K. Rosenthal-Aizman, Oprea II, O.E. Simonson, H. Sork, K. Ezzat, D.M. Copolovici, K. Kurrikoff, J.R. Viola, E.M. Zaghloul, R. Sillard, H.J. Johansson, F. Said Hassane, P. Guterstam, J. Suhorutsenko, P.M. Moreno, N. Oskolkov, J. Halldin, U. Tedebark, A. Metspalu, B. Lebleu, J. Lehtio, C.I. Smith, and Ü. Langel Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo Nucleic Acids Res. 39 9 2011 3972 3987
17. S.L. Lo, and S. Wang An endosomolytic Tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection Biomaterials 29 15 2008 2408 2414
18. T. Lehto, O.E. Simonson, I. Mäger, K. Ezzat, H. Sork, D.M. Copolovici, J.R. Viola, E.M. Zaghloul, P. Lundin, P.M. Moreno, M. Mäe, N. Oskolkov, J. Suhorutšenko, C.E. Smith, and S.E. Andaloussi A peptide-based vector for efficient gene transfer in vitro and in vivo Mol. Ther. 19 8 2011 1457 1467
19. T. Lehto, R. Abes, N. Oskolkov, J. Suhorutsenko, D.M. Copolovici, I. Mäger, J.R. Viola, O.E. Simonson, K. Ezzat, P. Guterstam, E. Eriste, C.I. Smith, B. Lebleu, A. Samir El, and Ü. Langel Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy J. Control. Release 141 1 2010 42 51
20. P. Lundberg, S. El-Andaloussi, T. Sütlü, H. Johansson, and Ü. Langel Delivery of short interfering RNA using endosomolytic cell-penetrating peptides FASEB J. 21 11 2007 2664 2671
21. S.H. Kang, M.J. Cho, and R. Kole Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development Biochemistry 37 18 1998 6235 6239
22. A. Eguchi, and S.F. Dowdy siRNA delivery using peptide transduction domains Trends Pharmacol. Sci. 30 7 2009 341 345
23. M.L. Edelstein, M.R. Abedi, and J. Wixon Gene therapy clinical trials worldwide to 2007 - an update J. Gene Med. 9 10 2007 833 842
24. F. Said Hassane, A.F. Saleh, R. Abes, M.J. Gait, and B. Lebleu Cell penetrating peptides: overview and applications to the delivery of oligonucleotides Cell Mol. Life Sci. 67 5 2010 715 726
25. P. Lundin, H. Johansson, P. Guterstam, T. Holm, M. Hansen, Ü. Langel, and S. EL Andaloussi Distinct uptake routes of cell-penetrating peptide conjugates Bioconjug. Chem. 19 12 2008 2535 2542
26. F. Duchardt, M. Fotin-Mleczek, H. Schwarz, R. Fischer, and R. Brock A comprehensive model for the cellular uptake of cationic cell-penetrating peptides Traffic 8 7 2007 848 866
27. A. El-Sayed, S. Futaki, and H. Harashima Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment AAPS J. 11 1 2009 13 22
28. E. Ramsay, and M. Gumbleton Polylysine and polyornithine gene transfer complexes: a study of complex stability and cellular uptake as a basis for their differential in-vitro transfection efficiency J. Drug Target. 10 1 2002 1 9
29. K. Ezzat, S. El Andaloussi, E.M. Zaghloul, T. Lehto, S. Lindberg, P.M. Moreno, J.R. Viola, T. Magdy, R. Abdo, P. Guterstam, R. Sillard, S.M. Hammond, M.J. Wood, A.A. Arzumanov, M.J. Gait, C.I. Smith, M. Hällbrink, and Ü. Langel PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation Nucleic Acids Res. 39 12 2011 5284 5298
30. D. Huang, N. Korolev, K.D. Eom, J.P. Tam, and L. Nordenskiold Design and biophysical characterization of novel polycationic epsilon-peptides for DNA compaction and delivery Biomacromolecules 9 1 2008 321 330
31. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 8 2010 615 627
32. A. Rydström, S. Deshayes, K. Konate, L. Crombez, K. Padari, H. Boukhhadaoui, G. Aldrian, M. Pooga, and G. Divita Direct translocation as major cellular uptake for CADY-self-assembling peptide based nanoparticles PLoS One 6 2011 e25924
33. S.J. DeWitte-Orr, S.E. Collins, C.M. Bauer, D.M. Bowdish, and K.L. Mossman An accessory to the 'trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses PLoS Pathog. 6 2010 e1000829
34. Y. Hayashi, J. Yamauchi, I.A. Khalil, K. Kajimoto, H. Akita, and H. Harashima Cell penetrating peptide-mediated systemic siRNA delivery to the liver Int. J. Pharm. 419 2011 308 313
35. A. Presente, and S.F. Dowdy PTD/CPP peptide-mediated delivery of siRNAs Curr. Pharm. Des. 19 2013
36. C.R. Dass Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection J. Mol. Med. 82 9 2004 579 591